Boadilla del Monte, Spain Clinical Trials

A listing of Boadilla del Monte, Spain clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 220 clinical trials
A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease.

The study is intended to show superiority of AZD9833 in combination with palbociclib (a CDK4/6 inhibitor) versus anastrozole (an aromatase inhibitor) and palbociclib as the initial treatment of patients with hormone receptor-positive (ER-positive), human epidermal growth factor 2-negative (HER2-negative) advanced/metastatic breast cancer.

Research Site
 (9.7 away) Contact site
  • 0 views
  • 27 Sep, 2021
  • +209 other locations
Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults

This Phase III study will assess whether AZD7442 (a combination of 2 mAbs) can safely treat outpatient adults with COVID-19 and prevent either severe COVID-19 or death.

Research Site
 (9.7 away) Contact site
  • 1 views
  • 09 Jul, 2021
  • +128 other locations
A Study of Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV)

The purpose of the study is to evaluate the efficacy of rilematovir compared to placebo treatment with respect to the clinical outcome on the RSV Recovery Scale (RRS).

congestion
respiratory tract infection
rsv infection
cough
wheezing
Hosp. Univ. Hm Monteprincipe
 (0.9 away) Contact site
  • 4 views
  • 10 Sep, 2021
  • +229 other locations
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902) or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib Versus Pembrolizumab and Lenvatinib for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)

The goal of this study is to evaluate the efficacy and safety of pembrolizumab plus belzutifan plus lenvatinib or pembrolizumab/quavonlimab plus lenvatinib versus pembrolizumab plus lenvatinib as first-line treatment in participants with advanced clear cell renal cell carcinoma (ccRCC). The primary hypotheses are (1) pembrolizumab plus belzutifan plus lenvatinib is …

carcinoma
clear cell renal cell carcinoma
systemic therapy
pembrolizumab
lenvatinib
Hospital Clinico San Carlos ( Site 1503)
 (8.2 away) Contact site
  • 3 views
  • 26 Sep, 2021
  • +92 other locations
A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Episodic Migraine

This study will evaluate the Long-Term Safety and Tolerability of Atogepant 60 mg daily for the Prevention of Migraine in Participants with Chronic or Episodic Migraine

Hospital Clinico San Carlos (Madrid)
 (8.2 away) Contact site
  • 0 views
  • 23 Sep, 2021
  • +177 other locations
A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid.

The purpose of this study is to investigate the use of benralizumab is effective in the treatment of patients symptomatic Bullous Pemphigoid (BP)

follicle stimulating hormone
Research Site
 (9.7 away) Contact site
  • 0 views
  • 23 Sep, 2021
  • +55 other locations
SY-1425 Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome

This study compares the efficacy of SY-1425 in combination with azacitidine to azacitidine in combination with placebo in participants who are Retinoic Acid Receptor Alpha (RARA) positive, and newly diagnosed with higher-risk myelodysplastic syndrome (MDS), and who have not received treatment for this diagnosis. The primary goal of the study …

azacitidine
remission
Hospital Universitario Fundacion Jimenez Diaz
 (8.2 away) Contact site
  • 0 views
  • 28 Sep, 2021
  • +81 other locations
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis Post Polycythemia Vera Myelofibrosis or Post-Essential Thrombocythemia Myelofibrosis

This study (study ID PAC203 North America; PAC303 ex-North America) is evaluating 200 mg BID of pacritinib compared to physician's choice (P/C) therapy in patients with MF and severe thrombocytopenia (platelet count <50,000/L). Approximately 348 patients in total will be enrolled, randomized 2:1 to either pacritinib (approximately 232 patients) or …

ejection fraction
thrombocytosis
platelet count
ruxolitinib
essential thrombocythemia
Hospital Universitario Ram n y Cajal
 (9.7 away) Contact site
  • 506 views
  • 21 Aug, 2021
  • +177 other locations
Study to Assess Efficacy and Safety of Cx601 Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD)

The purpose of this study is to evaluate the combined remission of complex perianal fistulas, defined as the clinical assessment at Week 24 of closure of all treated external openings that were draining at baseline despite gentle finger compression, and absence of collections greater than (>) 2 centimeter (cm) (in …

ulceration
infliximab
adalimumab
certolizumab pegol
ustekinumab
Hospital Universitario Puerta de Hierro Majadahonda
 (4.7 away) Contact site
  • 202 views
  • 28 May, 2021
  • +177 other locations
High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN)

This is a randomized study of the European SIOP Neuroblastoma Group (SIOPEN) in high-risk neuroblastoma (stages 2, 3, 4 and 4s MYCN-amplified neuroblastoma, stage 4 MYCN non amplified > 12 months at diagnosis). The protocol consists of a rapid, dose intensive induction chemotherapy, peripheral blood stem cell harvest, attempted complete …

topotecan
cyclophosphamide
melphalan
mycn protein
doxorubicin
H. Monteprincipe
 (9.7 away) Contact site
  • 288 views
  • 26 Jan, 2021
  • +125 other locations